Hepatic Steatosis and Elevated Acid Load in Uric Acid Stone Formers: Evidence for a Hepato-Renal Axis

Background: Uric acid (UA) nephrolithiasis is characterized by persistently elevated net acid excretion (NAE) and low urine pH and seen mostly in individuals with obesity and metabolic syndrome. While the mechanisms underlying this aciduria remain incompletely understood, hepatic steatosis and elevated concentration of circulating free fatty acids (FFAs) have been suggested as potential contributors. Methods: Twenty-one UASF and eighteen matched non-stone formers (NSF) were placed under a fixed 5-day metabolic diet. 24-hour urine and fasting blood samples were collected. Hepatic fat content was quantified by magnetic resonance imaging. Results: UASF and NSF were comparable in age, sex, and body mass index. Compared to NSF, UASF exhibited significantly lower 24-hour urine pH (5.4 vs. 6.0, p<0.001), higher NAE, and a lower fraction of NAE excreted as ammonium (NH4+/NAE: 0.71 vs. 0.89, p=0.008). Hepatic fat content was markedly higher in UASF (12.9% vs. 3.7%, p<0.001) and positively correlated with NAE (r = 0.48, p = 0.04). Serum FFA was higher in UASF (0.71 vs. 0.57 mEq/L) and positively correlated with liver fat in UASF. The association between liver fat and NAE was attenuated after adjusting for serum FFAs (p = 0.07). Conclusion: This is the first study to implicate hepatic steatosis in the pathogenesis of UA nephrolithiasis. The strong association between liver fat and NAE suggests that hepatic steatosis contributes to the aciduria in UASF. Elevated FFAs, a hallmark of hepatic and visceral adiposity, at least in part contribute to hepatic steatosis and the greater NAE , possibly by promoting a metabolic substrate shift from amino acids to fatty acids, which could enhance organic acid generation but also impair renal ammoniagenesis by limiting amino acid availability. These findings support the presence of a hepato-renal metabolic axis in UA stone disease, in which hepatic steatosis and FFA-driven metabolic dysfunction contribute to persistent aciduria and UA stone formation. Funding: NIDDK Support

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025483pxd2c
Primary Topic
Kidney Stones and Urolithiasis Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hepatic Steatosis and Elevated Acid Load in Uric Acid Stone Formers: Evidence for a Hepato-Renal Axis

Orson W. Moe, Alireza Zomorodian, Naim M. Maalouf, Khashayar Sakhaee et al.
Journal of the American Society of Nephrology
Kidney Stones and Urolithiasis Treatments
article

Hepatic Steatosis and Elevated Acid Load in Uric Acid Stone Formers: Evidence for a Hepato-Renal Axis

Orson W. Moe, Alireza Zomorodian, Naim M. Maalouf, Khashayar Sakhaee, Xilong Li
article en

Abstract

Background: Uric acid (UA) nephrolithiasis is characterized by persistently elevated net acid excretion (NAE) and low urine pH and seen mostly in individuals with obesity and metabolic syndrome. While the mechanisms underlying this aciduria remain incompletely understood, hepatic steatosis and elevated concentration of circulating free fatty acids (FFAs) have been suggested as potential contributors. Methods: Twenty-one UASF and eighteen matched non-stone formers (NSF) were placed under a fixed 5-day metabolic diet. 24-hour urine and fasting blood samples were collected. Hepatic fat content was quantified by magnetic resonance imaging. Results: UASF and NSF were comparable in age, sex, and body mass index. Compared to NSF, UASF exhibited significantly lower 24-hour urine pH (5.4 vs. 6.0, p<0.001), higher NAE, and a lower fraction of NAE excreted as ammonium (NH4+/NAE: 0.71 vs. 0.89, p=0.008). Hepatic fat content was markedly higher in UASF (12.9% vs. 3.7%, p<0.001) and positively correlated with NAE (r = 0.48, p = 0.04). Serum FFA was higher in UASF (0.71 vs. 0.57 mEq/L) and positively correlated with liver fat in UASF. The association between liver fat and NAE was attenuated after adjusting for serum FFAs (p = 0.07). Conclusion: This is the first study to implicate hepatic steatosis in the pathogenesis of UA nephrolithiasis. The strong association between liver fat and NAE suggests that hepatic steatosis contributes to the aciduria in UASF. Elevated FFAs, a hallmark of hepatic and visceral adiposity, at least in part contribute to hepatic steatosis and the greater NAE , possibly by promoting a metabolic substrate shift from amino acids to fatty acids, which could enhance organic acid generation but also impair renal ammoniagenesis by limiting amino acid availability. These findings support the presence of a hepato-renal metabolic axis in UA stone disease, in which hepatic steatosis and FFA-driven metabolic dysfunction contribute to persistent aciduria and UA stone formation. Funding: NIDDK Support

Journal of the American Society of NephrologyVol. 36(10S)
The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 57%
Kidney Stones and Urolithiasis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.